SMTL ID : 6s7h.1

Human CD73 (5'-nucleotidase) in complex with PSB12489 (an AOPCP derivative) in the closed state

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-dimer

Ligands

4 x ZN: ZINC ION(Non-covalent)

ZN.1: 9 residues within 4Å: Chain A: D.11, H.13, D.60, H.93, H.195, H.218, R.370 Ligands: ZN.2, KYW.4 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.11, A:H.13, A:D.60, H2O.2 ZN.2: 8 residues within 4Å: Chain A: D.11, D.60, N.92, H.93, H.195, H.218 Ligands: ZN.1, KYW.4 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.60, A:H.195, A:H.218 ZN.5: 9 residues within 4Å: Chain B: D.11, H.13, D.60, H.93, H.195, H.218, R.370 Ligands: ZN.6, KYW.8 4 PLIP interactions: 3 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.11, B:H.13, B:D.60, H2O.14 ZN.6: 8 residues within 4Å: Chain B: D.11, D.60, N.92, H.93, H.195, H.218 Ligands: ZN.5, KYW.8 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:D.60, B:H.195, B:H.218

2 x CA: CALCIUM ION(Non-covalent)

CA.3: 7 residues within 4Å: Chain A: K.183, N.188, K.189, I.190, D.212, G.273, N.274 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:N.188, A:D.212, A:G.273, H2O.1, H2O.6 CA.7: 7 residues within 4Å: Chain B: K.183, N.188, K.189, I.190, D.212, G.273, N.274 5 PLIP interactions: 3 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:N.188, B:D.212, B:G.273, H2O.13, H2O.18

2 x KYW: (N6,N6)-methyl,benzyl-C2-chloro-(alpha,beta)-methylene-ADP(Non-covalent)

KYW.4: 24 residues within 4Å: Chain A: D.11, H.13, D.60, N.92, H.93, D.96, F.158, L.159, S.160, N.161, H.218, N.220, R.329, N.365, G.367, G.368, R.370, F.392, G.422, P.473, F.475, D.481 Ligands: ZN.1, ZN.2 15 PLIP interactions: 15 interactions with chain A Hydrogen bonds: A:N.92, A:N.220, A:N.220, A:R.329, A:R.329, A:N.365, A:G.367, A:R.370, A:R.370, A:G.422 Water bridges: A:E.423, A:D.481 pi-Stacking: A:F.392, A:F.475, A:F.475 KYW.8: 24 residues within 4Å: Chain B: D.11, H.13, D.60, N.92, H.93, D.96, F.158, L.159, S.160, N.161, H.218, N.220, R.329, N.365, G.367, G.368, R.370, F.392, G.422, P.473, F.475, D.481 Ligands: ZN.5, ZN.6 13 PLIP interactions: 13 interactions with chain B Hydrogen bonds: B:N.92, B:N.220, B:N.220, B:R.329, B:R.329, B:N.365, B:G.367, B:R.370, B:R.370, B:G.422 pi-Stacking: B:F.392, B:F.475, B:F.475

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bhattarai, S. et al., X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) Inhibitors for Cancer Immunotherapy. Adv Ther (2019)

Release Date

2020-07-22

Peptides

5'-nucleotidase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

5'-nucleotidase

Related Entries With Identical Sequence